oxyclozanide has been researched along with niclosamide in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barak, LS; Chen, M; Chen, W; Lu, J; Lyerly, HK; Mook, RA | 1 |
| Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
| Constant, P; Daffé, M; Guillet, V; Le, NH; Marrakchi, H; Maveyraud, L; Mourey, L; Nahoum, V; Tranier, S; Verhaeghe, P | 1 |
| Boray, JC; Rolfe, PF | 1 |
| Ausubel, FM; Conery, AL; Fuchs, BB; Jayamani, E; Kim, W; Kwon, B; Mylonakis, E; Rajamuthiah, R | 1 |
| AbdelKhalek, A; Abutaleb, NS; Mohammad, H; Seleem, MN | 1 |
| Alasadi, A; Chen, M; Collantes, J; Fadhil, N; Guo, J; Jin, S; Montelione, GT; Swapna, GVT; Tao, H | 1 |
| Berastegui-Cabrera, J; Marrugal-Lorenzo, JA; Pachón, J; Sánchez-Céspedes, J; Serna-Gallego, A | 1 |
8 other study(ies) available for oxyclozanide and niclosamide
| Article | Year |
|---|---|
Small molecule modulators of Wnt/β-catenin signaling.
Topics: beta Catenin; Cell Line, Tumor; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Molecular Structure; Niclosamide; Small Molecule Libraries; Structure-Activity Relationship; Wnt Signaling Pathway | 2013 |
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |
Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis.
Topics: Adenosine Monophosphate; Antitubercular Agents; Drug Evaluation, Preclinical; Humans; Mycobacterium tuberculosis; Salicylanilides; Tuberculosis | 2022 |
Chemotherapy of paramphistomosis in cattle.
Topics: Animals; Anthelmintics; Cattle; Cattle Diseases; Feces; Female; Hexachlorophene; Ionophores; Levamisole; Niclosamide; Oxyclozanide; Paramphistomatidae; Parasite Egg Count; Salicylanilides; Trematode Infections | 1987 |
Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus.
Topics: Animals; Anthelmintics; Anti-Bacterial Agents; Cell Survival; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Erythrocytes; Gram-Negative Bacteria; Hep G2 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Niclosamide; Oxyclozanide; Sheep | 2015 |
Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci.
Topics: Animals; Anti-Bacterial Agents; Depsipeptides; Drug Repositioning; Feces; Humans; Intestines; Linezolid; Mice; Microbial Sensitivity Tests; Niclosamide; Oxyclozanide; Rafoxanide; Salicylanilides; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2018 |
Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer.
Topics: Animals; Antinematodal Agents; Colonic Neoplasms; Ethanolamine; Humans; Liver Neoplasms; Mice; Niclosamide; Oxyclozanide | 2018 |
Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections.
Topics: A549 Cells; Adenoviridae; Adenoviridae Infections; Antiviral Agents; Community-Acquired Infections; Drug Repositioning; HEK293 Cells; Humans; Niclosamide; Oxyclozanide; Rafoxanide | 2019 |